As of 2026-04-06, the Relative Valuation of Health Catalyst Inc (HCAT) is (40.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.17 USD, the upside of Health Catalyst Inc based on Relative Valuation is -3603.7%.
The range of the Relative Valuation is (39.28) - (45.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 18.9x | 17.6x |
| Forward P/E multiples | 16.2x - 19.8x | 16.3x |
| Fair Price | (39.28) - (45.76) | (40.99) |
| Upside | -3456.9% - -4010.9% | -3603.7% |
| Date | P/E |
| 2026-04-02 | -0.48 |
| 2026-04-01 | -0.48 |
| 2026-03-31 | -0.53 |
| 2026-03-30 | -0.49 |
| 2026-03-27 | -0.45 |
| 2026-03-26 | -0.45 |
| 2026-03-25 | -0.45 |
| 2026-03-24 | -0.45 |
| 2026-03-23 | -0.50 |
| 2026-03-20 | -0.51 |
| 2026-03-19 | -0.50 |
| 2026-03-18 | -0.48 |
| 2026-03-17 | -0.48 |
| 2026-03-16 | -0.50 |
| 2026-03-13 | -0.55 |
| 2026-03-12 | -0.74 |
| 2026-03-11 | -0.77 |
| 2026-03-10 | -0.75 |
| 2026-03-09 | -0.79 |
| 2026-03-06 | -0.81 |
| 2026-03-05 | -0.80 |
| 2026-03-04 | -0.81 |
| 2026-03-03 | -0.71 |
| 2026-03-02 | -0.69 |
| 2026-02-27 | -0.67 |
| 2026-02-26 | -0.72 |
| 2026-02-25 | -0.74 |
| 2026-02-24 | -0.72 |
| 2026-02-23 | -0.70 |
| 2026-02-20 | -0.74 |
| 2026-02-19 | -0.77 |
| 2026-02-18 | -0.73 |
| 2026-02-17 | -0.72 |
| 2026-02-13 | -0.76 |
| 2026-02-12 | -0.76 |
| 2026-02-11 | -0.82 |
| 2026-02-10 | -0.85 |
| 2026-02-09 | -0.89 |
| 2026-02-06 | -0.89 |
| 2026-02-05 | -0.86 |
| 2026-02-04 | -0.90 |
| 2026-02-03 | -0.90 |
| 2026-02-02 | -0.95 |
| 2026-01-30 | -0.89 |
| 2026-01-29 | -0.89 |
| 2026-01-28 | -0.91 |
| 2026-01-27 | -0.92 |
| 2026-01-26 | -0.91 |
| 2026-01-23 | -0.93 |
| 2026-01-22 | -0.98 |